What's new?‐The CONCEPTT trial showed that real‐time continuous glucose monitoring (CGM) was associated with improvements in maternal glycaemic control and in neonatal health outcomes.‐The number‐needed‐to‐treat with CGM to prevent large‐for‐gestational‐age infants or neonatal intensive care unit admission >24 h was six, and to prevent a case of neonatal hypoglycaemia it was eight.‐Further issues include the use of newer technologies with improved patient satisfaction, and closed‐loop therapy may further improve outcomes.‐High rates of large infants despite treatment remain a challenge, and future investigations must assess the impact of dietary factors, glucose variability and information gleaned from metabolomics.IntroductionDiabetes is the commonest pre‐existing medical condition in pregnancy, affecting 1.5% of pregnancies . Approximately half of all pregnancies in women with pre‐existing diabetes are complicated by Type 1 diabetes, and the remainder by Type 2 diabetes and other forms of monogenic diabetes . The prevalence of Type 1 diabetes in young people has doubled in the past two decades, meaning that in the future even more women will enter pregnancy with potentially more complicated Type 1 diabetes and diabetes of longer duration . National audit data highlight the prevalence of suboptimal control of maternal glucose levels before and during pregnancy . The most
Diabetic Medicine – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera